The Alabama Vaccine Research Clinic (AVRC) at UAB is seeking healthy adults ages 18 to 65 to take part in a national HIV prevention study. This Phase 2 clinical trial is testing the safety and potential benefits of three investigational monoclonal antibodies—lab-made proteins that may help the body block HIV. These antibodies are given by IV infusion, not as a shot or vaccine, and participants are never exposed to HIV. Those who qualify will receive two infusions over six months, followed by routine clinic visits for up to one year. Participants will receive compensation for their time and effort. To learn more, call 205-934-7492, email This email address is being protected from spambots. You need JavaScript enabled to view it..